1[1]Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Research, 2001, 21 (4) :3085
2[2]Niklinski J, Furman M, Burzyowski T. Preoperative CYFRA21-1 level as aprognostic in resected primary squamous cell lung cancer. B J Cancer, 1996, 74:956
3[3]Antonio LP, Antonio JT, Marisa M. Quantitative analysis of CEA, SCC, CA125, and CA50 cytosolic content in NSCLC.Cancer, 1996, 73 (9) :2305
4[4]Jan K, Ewa W, Andrzej R. C RA21-1, TPA, TPS, SCC and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group. Anticancer Research,2000, 20:5035
6[6]Kulpa J, Wojcik E, Reinfuss M. Carcinoembryonic antigen,squamous cell carcinoma antigen, CYFRA 21-1, and neuronspecific enolase in squamous cell lung cancer patients. Clinical Chemistry, 2002, 48 (11) :1931
7[7]DiezM, CerdanFJ, Ortega MD. Evaluation ofserum CA125 as a tumor markerin NSCLC. Cancer, 1991, 67:150
8[8]Jan K, Ewa W, Marian R, et al. CEA, SCC, CYFRA21-1 and NSE in squamous cell lungcancer patients. Clinical Chemistry, 2002, 48 (11) :1931
9[9]Alatas F, Alatas O, Metintas M. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay inpleural effusions. Lung cancer, 2001, 31 (1) :9
10[10]Dize M, Torres A, Pollan M. Prognostic significance of serum CA125 assay inpatients with NSCLC. Cancer, 1994, 73 (5): 1368
